We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.93B
AUM Growth
+$1.15B
Cap. Flow
+$1.17B
Cap. Flow %
23.66%
Top 10 Hldgs %
15.43%
Holding
758
New
275
Increased
122
Reduced
113
Closed
194

Top Sells

Rank Stock Value
1
CUZ icon
Cousins Properties
CUZ
+$87.3M
2
VICI icon
VICI Properties
VICI
+$58.6M
3
VTR icon
Ventas
VTR
+$50.3M
4
BXP icon
Boston Properties
BXP
+$39.8M
5
COLD icon
Americold
COLD
+$34.5M

Sector Composition

Rank Sector Weight
1 Real Estate 18.43%
2 Technology 10.03%
3 Industrials 7.7%
4 Healthcare 6.67%
5 Energy 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRQS
551
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$168K ﹤0.01%
+486
New +$220K
DVAX
552
DELISTED
Dynavax Technologies
DVAX
$161K ﹤0.01%
45,000
UROV
553
DELISTED
Urovant Sciences Ltd.
UROV
$145K ﹤0.01%
15,335
-9,665
-39% -$83.8K
FENC icon
554
Fennec Pharmaceuticals
FENC
$357M
$120K ﹤0.01%
25,000
ACH
555
Accendra Health
ACH
$250M
$116K ﹤0.01%
20,000
SCOR icon
556
CALL
Comscore
SCOR
$108M
$96K ﹤0.01%
+2,500
New +$144K
GRCE
557
Grace Therapeutics
GRCE
$38.2M
$95K ﹤0.01%
+1,042
New +$96.5K
FOLD
558
CALL
DELISTED
Amicus Therapeutics
FOLD
$80K ﹤0.01%
+10,000
New +$109K
ITCI
559
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$75K ﹤0.01%
10,000
-11,000
-52% -$105K
TYME
560
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$64K ﹤0.01%
53,500
-6,500
-11% -$8.19K
AGTC
561
DELISTED
Applied Genetic Technologies Corporation
AGTC
$62K ﹤0.01%
+15,000
New +$54.2K
OPK icon
562
Opko Health
OPK
$929M
$52K ﹤0.01%
25,000
ALIM
563
DELISTED
Alimera Sciences
ALIM
$48K ﹤0.01%
5,600
NTGN
564
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$19K ﹤0.01%
11,000
AAL icon
565
PUT
American Airlines Group
AAL
$9.71B
-40,000
Closed -$1.3M
AAPL icon
566
CALL
Apple
AAPL
$4.96T
-100,000
Closed -$4.95M
ADBE icon
567
Adobe
ADBE
$94.7B
-15,000
Closed -$4.42M
ADAP
568
DELISTED
Adaptimmune Therapeutics
ADAP
-40,000
Closed -$161K
ADI icon
569
Analog Devices
ADI
$178B
-50,000
Closed -$5.64M
ADP icon
570
Automatic Data Processing
ADP
$102B
-37,500
Closed -$6.2M
ADSK icon
571
Autodesk
ADSK
$47.2B
-20,000
Closed -$3.26M
AEE icon
572
Ameren
AEE
$31.1B
-143,000
Closed -$10.7M
AER icon
573
PUT
AerCap
AER
$23.8B
-30,000
Closed -$1.56M
AGO icon
574
Assured Guaranty
AGO
$3.8B
-200,000
Closed -$8.8M
AKR icon
575
Acadia Realty Trust
AKR
$3.01B
-373,602
Closed -$10.2M

Similar funds

Weiss Multi-Strategy Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Weiss Multi-Strategy Advisers held 758 positions worth $4.93B, up 30% from $3.78B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Weiss Multi-Strategy Advisers deployed $1.17B of net new capital in Q3 2019, opening 275 new positions and adding to 122 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was VICI Properties, an estimated $58.6M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q3 2019 buy was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.
  • Weiss Multi-Strategy Advisers added most to Celgene Corp in Q3 2019, an estimated $106M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2019 reduction was VICI Properties, cutting an estimated $58.6M.
  • Weiss Multi-Strategy Advisers fully exited Cousins Properties in Q3 2019, selling an estimated $87.3M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 15% of its $4.93B portfolio in Q3 2019.
  • Weiss Multi-Strategy Advisers opened 275 new positions and closed 194 in Q3 2019.
  • Weiss Multi-Strategy Advisers's portfolio value rose 30% quarter-over-quarter to $4.93B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.